Corporate Tech Investors

Eli Lilly and Company

Eli Lilly and Company is a corporate VC investing group that partners with companies that are a good strategic fit.

Venture Investor Overview

Venture Investor
Eli Lilly and Company
Status
Active
Investor Type
Corporate
Activity Level
Funds Raised
Industry Focus
Artificial Intelligence
Biopharmaceutical
Healthcare IT
Healthcare Services
Life Sciences
Medical Devices & Instruments
Software

Contact Information

Contact
David Ricks
Title
Chief Executive Officer
Mailing Address
Lilly Corporate Center
Indianapolis, IN 46285
USA
Email Address

Background Information

Overview
Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: Take what you find here and make it better and better. More than 140 years later, we remain committed to his vision through every aspect of our business and the people we serve starting with those who take our medicines, and extending to health care professionals, employees and the communities in which we live.
Profile
Eli Lilly and Company LinkedIn Company Profile
Social Media
Eli Lilly and Company Company Twitter Account
Company News
Eli Lilly and Company News
Facebook
Eli Lilly and Company on Facebook
YouTube
Eli Lilly and Company on YouTube
Last Transaction
11/18/2024

Transaction History

Our records indicate that Eli Lilly and Company invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
11/18/2024
$4,000,000
11/14/2024
$84,000,000
10/16/2024
$14,000,000
10/9/2024
$43,000,000
10/9/2024
$6,000,000
9/30/2024
$175,000,000
9/10/2024
$13,000,000
9/9/2024
$120,000,000
9/6/2024
$67,000,000
8/6/2024
$8,000,000
7/26/2024
$10,000,000
7/8/2024
$115,000,000
6/26/2024
$18,000,000
5/23/2024
$13,400,000
5/13/2024
$95,000,000
3/21/2024
$175,000,000
3/13/2024
$111,000,000
2/15/2024
$94,000,000
1/26/2024
$10,300,000
1/23/2024
$24,000,000
1/8/2024
Unknown
11/21/2023
$45,000,000
9/28/2023
$16,466,000
9/27/2023
$39,000,000
8/3/2023
$26,000,000
7/11/2023
$80,000,000
6/26/2023
$53,000,000
6/7/2023
$25,000,000
5/10/2023
$29,996,000
3/22/2023
$123,000,000
3/15/2023
$105,000,000
3/14/2023
$52,000,000
3/7/2023
$60,000,000
2/7/2023
$40
12/5/2022
$60,750,000
11/28/2022
$45,000,000
9/8/2022
$75,000,000
7/20/2022
$48,000,000
7/18/2022
$225,000,000
5/12/2022
$26,000,000
2/18/2022
$64,000,000
1/27/2022
$150,000,000
12/21/2021
$98,000,000
11/19/2021
$15,000,000
10/30/2021
$55,000,000
9/27/2021
$26,000,000
9/15/2021
$85,000,000
8/4/2021
$30,000,000
6/23/2021
$59,000,000
6/18/2021
$66,000,000
6/9/2021
$56,100,000
4/14/2021
$139,000,000
3/4/2021
$100,000,000
2/10/2021
$40,000,000
1/13/2021
Unknown
1/6/2021
$87,000,000
10/14/2020
$57,600,000
5/28/2020
$105,000,000
3/18/2020
$80,300,000
3/3/2020
$130,000,000

 


Investor Contacts

Title
Name
Email & Social
Chief Executive Officer
David Ricks
  David Ricks LinkedIn Profile  David Ricks Twitter Account  David Ricks News  David Ricks on Facebook

 


Funds

No fund closings have been recorded for this company.

 


Portfolio Companies

Eli Lilly and Company has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more corporate investors:

ElevateBio | Elron Electronic Industries

 

Share this article

 


About Our Corporate Tech Investor Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary